SUPV3L1/ELAC2快速降解mecciRNA为心衰治疗提供新策略
该研究揭示线粒体编码环状RNA(mecciRNA)被SUPV3L1/ELAC2复合物快速降解,mecciRNA通过调控线粒体通透性转换孔调节活性氧释放。心衰条件下mecciRNA降解增强,外源性给予体外合成的mecciRNA在阿霉素和压力负荷诱导的小鼠心衰模型中表现出显著保护作用。
要点
- mecciRNA由SUPV3L1/ELAC2复合物快速降解,与核编码环状RNA的稳定性不同。
- mecciRNA通过TRAP1和CypD调控线粒体通透性转换孔及活性氧释放。
- 外源性mecciRNA在小鼠心衰模型中显示治疗潜力。
核心结论
- mecciRNA被SUPV3L1/ELAC2复合物快速降解,心衰时降解失调,外源性mecciRNA在小鼠心衰模型中具有治疗潜力。
研究设计与样本
- 研究结合RNA测序及分子、生化、细胞实验鉴定mecciRNA降解特征,并在阿霉素和压力负荷诱导的小鼠心衰模型中测试体外合成mecciRNA的保护效应。
主要发现
- mecciRNA被SUPV3L1和ELAC2组成的保守复合物迅速降解。
- mecciRNA降解复合物及mecciRNA与线粒体通透性转换孔及其调节因子TRAP1和CypD相互作用。
- mecciRNA调节线粒体TRAP1和CypD水平,从而调控线粒体通透性转换孔开放和活性氧释放。
- 外源性mecciRNA与胞质TRAP1相互作用,增加线粒体TRAP1水平,促使线粒体通透性转换孔更趋向关闭状态以限制有害活性氧释放。
- 心衰条件下mecciRNA降解受刺激,给予体外合成mecciRNA在两种小鼠心衰模型中均表现出显著保护作用。
临床怎么用
- 外源性mecciRNA可能作为心衰治疗的新策略,但尚未在人体验证。
局限性
- 研究仅在小鼠心衰模型中进行,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells. Mitochondria-encoded circular RNAs (mecciRNAs) are attracting more attention, and several members of mecciRNAs have already been recognized in regulating mitochondrial functions. Mitochondria dysfunctions are well-known to participate in heart failure (HF). This study was designed to investigate the RNA metabolism of mecciRNAs and the relevant roles and potential application of mecciRNAs in HF. METHODS: Compared with highly stable nuclear genome-encoded circular RNAs, the fast degradation feature of mecciRNAs is identified by RNA sequencing and a series of molecular, biochemical, and cellular experiments. The substantial protective effects of in vitro synthesized mecciRNAs were tested in both doxorubicin- and pressure overload-induced mouse models of HF. RESULTS: We discover that mecciRNAs are promptly degraded by an animal-conserved complex of helicase SUPV3L1 (suppressor of var1, 3-like protein 1) and endoribonuclease ELAC2 (elaC ribonuclease Z 2). MecciRNA degradation complex and mecciRNAs interact with mitochondrial permeability transition pore and its regulators including TRAP1 (TNF receptor-associated protein 1) and CypD (cyclophilin D). MecciRNAs regulate mitochondrial levels of TRAP1 and CypD to modulate the opening of mitochondrial permeability transition pore and the release of mitochondrial reactive oxygen species. Exogenously applied mecciRNAs interact with cytosolic TRAP1 and increase mitochondrial levels of TRAP1, and lead to a more closed state of mitochondrial permeability transition pore to constrain deleterious reactive oxygen species release. HF conditions lead to stimulated mecciRNA degradation, and administration of in vitro synthesized mecciRNAs exhibits substantial protective effects in both doxorubicin- and pressure overload-induced mouse models of HF. CONCLUSIONS: This study demonstrates the fast degradation of mecciRNAs and the associated regulations of mitochondrial reactive oxygen species release of mitochondrial permeability transition pore by mecciRNAs. HF conditions lead to dysregulated mecciRNA degradation, and exogenous mecciRNAs demonstrate treatment potential in mouse models of HF.
引用
- Liu, Wang, Li, et al. Fast Degradation of MecciRNAs by SUPV3L1/ELAC2 Provides a Novel Opportunity to Tackle Heart Failure With Exogenous MecciRNA. Circulation. 2025. PMID: 39973625. doi:10.1161/CIRCULATIONAHA.124.070840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。